Readyserve Oral Liquid

Suppresses estrus in active mares
Regulates breeding cycle timing
Supports high-risk pregnancies
Enhances fertility program success
Reduces hormone fluctuation symptoms

Our Veterinarian Rate
4.5 out of 5
GCC Trusted Shipping
Learn more
Return Policy
Learn more
Secure Payments
Product Details

Altrenogest is a synthetic progestogen that mimics endogenous progesterone. It suppresses estrus and prevents ovulation by inhibiting the release of gonadotropins from the hypothalamic-pituitary axis. Upon withdrawal, mares resume natural cycles and return to estrus within days.


Recent Pharmaceutical Advancement:

  • Injectable Formulation Developed

  • Sustained blood levels for 5–7 days post-administration

  • Ensures consistent estrus suppression in cycling mares

  • Reduces need for daily dosing (compared to oral formulations)


Indications for Use:

Oral Liquid Administration:

  • Induces ovulatory estrus early in season

  • Suppresses estrus during training, travel, or competition

  • Controls ovarian activity for breeding program efficiency

  • Maintains pregnancy in mares with suspected progesterone deficiency

Injectable Use:

  • Suppresses estrus for 5–7 days

  • Repeat injections may be administered at defined intervals

  • Supports pregnancy maintenance in mares with luteal dysfunction


Pharmacokinetic Profile:

  • Sustained release over 5–7 days

  • Maintains therapeutic plasma levels for optimal efficacy

  • Enables precise scheduling of reproductive interventions


Key Benefits:
Suppresses estrus in active mares
Regulates breeding cycle timing
Supports high-risk pregnancies
Enhances fertility program success
Reduces hormone fluctuation symptoms


Administration and Dosage:

  • Oral Form: Daily as directed

  • Injection: Intramuscular, every 5–7 days

  • Dosage per weight and indication

  • Veterinarian-only administration required

Directions

Please refer to the product label or consult with your veterinarian for specific dosing recommendations.

Composition

Altrenogest 2.2 mg/mL in a medium chain triglyceride solution